CIO Bulletin, an interactive leadership platform, has named Valor Compounding Pharmacy one of the 50 Best Companies to Watch. The distinction comes hand in hand with an exclusive interview featuring Valor’s Vice President and Chief Pharmacy Officer, Christine Stephanos, who highlights why Valor is the pharmacy of choice for prescribers seeking quality compounded medications.
City of Hope, a world-renowned cancer research and treatment center, has identified how cancer cells in patients with early-stage breast cancer change and become resistant to hormone or combination therapies, according to a new study published in Nature Cancer.
Valor Compounding Pharmacy is quickly becoming the go-to telehealth compounding pharmacy for prescribers and companies across the United States. Now licensed in 23 states, Valor is excited to provide custom compounded medications across the country. Specializing in compounded medication, Valor meets each patient's unique needs and aims to be nationwide by the year 2022.